Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical Practice

Open access
Tester, David J., Ackerman, Michael J.·2011·Circulation

Abstract

The molecular millennium has bestowed researchers with the essential tools to identify the underlying genetic substrates for thousands of genetic disorders, most of which are rare and follow mendelian inheritance patterns. The genetic bases of potentially lethal and heritable cardiomyopathies and cardiac channelopathies, including hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), left ventricular noncompaction, arrhythmogenic right ventricular cardiomyopathy (ARVC), long-QT syndrome (LQTS), short-QT syndrome (SQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), Brugada syndrome (BrS), and familial atrial fibrillation, have been identified and are now better understood. Marked genetic heterogeneity and clinical heterogeneity are hallmark features of these disorders, with multiple genes and allelic variants subserving their underlying pathogenic mechanisms. To date, thousands of gene mutations at the single-nucleotide level have been discovered for this group of divergent cardiovascular disorders of the heart. Most mutations represent pathogenic disease-causing mutations only discovered in disease cohorts, whereas others are common or rare genetic polymorphisms identified in disease and in health that may or may not provide the precise pathogenic substrate. Genetic testing for several of these heritable cardiomyopathies and channelopathies has made its transition from discovery through translation, with clinical genetic tests now available commercially. The purpose of the present review is to provide the reader with a foundational understanding of genetic testing in clinical practice. Here, we will present some general principles of genetic testing, the need for careful interpretation of genetic testing results, the importance of genetic counseling, and some points on the ethical, legal, and societal implications of genetic testing. We will conclude by reviewing the state of clinical genetic testing for 4 of the principal cardiomyopathies/channelopathies: HCM, LQTS, CPVT, and BrS. ### Mutation Types in Human Genetic Disease Genes contain an encrypted genetic message for the assembly of polypeptides or proteins that serve the biological function of the cell. Polypeptides or proteins are polymers of linear repeating units …

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.109.914838

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 196

Metadata

Authors
Tester, D. J., & Ackerman, M. J.
Venue
Circulation
Published
2011-03-08
Volume
123
Issue
9
Pages
1021-1037
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W1978794954
Cited by
196
References
2
FWCI
19.28
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical Practice. https://app.cochat.ai/papers/10.1161/circulationaha.109.914838
The paper
Tester, D. J., & Ackerman, M. J. (2011). Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical Practice. Circulation. https://doi.org/10.1161/circulationaha.109.914838

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.